This article is more than 5 years old. Information may no longer be current.
DDW 2018: Advances in gastroenterology, hepatology, more
Click Here to Manage Email Alerts
WASHINGTON, D.C. — Over the next four days, the gastroenterology community will convene in the nation’s capital for Digestive Disease Week 2018, the specialty’s largest scientific conference.
Healio Gastroenterology and Liver Disease will be onsite at Walter E. Washington Convention Center starting June 2, providing updates on breaking research and scientific seminars until the meeting concludes June 5. Following the meeting, we will partner with the American College of Gastroenterology to provide expert perspective on a variety of topics in a series of weekly newswires.
Co-sponsored by the American Gastroenterological Association, American Association for the Study of Liver Diseases, American Society for Gastrointestinal Endoscopy and The Society for Surgery of the Alimentary Tract, DDW brings together clinicians, researchers and academics from all the specialties for four days of ground-breaking research, thought-provoking discussions and valuable networking opportunities.
Grace Elta, MD, chair of the DDW Council told Healio Gastroenterology and Liver Disease that they always try to add some new programs, and this year is no different. The organizers have broken the meeting up into specialized tracks, including basic science, clinical practice and inflammatory bowel disease, to help attendees cut down the meeting complexity and choose the programs that interest them most.
“You can search everything by track and figure out what you’re going to do,” Elta said. “We’re trying to make it a little easier to navigate.”
New research on a variety of topics, from colorectal cancer to bariatric endoscopy, will be presented at the meeting.
Prior to the meeting, DDW highlighted new research that will be presented by Francisco Leon, MD, PhD, about a new drug that could help patients with celiac disease avoid accidental gluten exposure, as well as a study by Michael B. Wallace, MD, on a new methylene blue dye tablet that could help improve adenoma detection rates during colorectal cancer screening.
Elta said the meeting’s registration numbers are on par with past meetings and that the diverse program will cover virtually all aspects of the specialty.
“We have ‘Meet the Professor’ sessions where you have small groups that are much more interactive, and then we have, of course, the huge lecture halls,” she said. “There’s a little bit of everything. It’s a great meeting.”
Healio Gastroenterology and Liver Disease staff will report live on breaking news presented at the meeting and capture video interviews with experts to gain their perspectives on important presentations. Visit Healio.com/GI and follow @HealioGastro and @HealioHep on Twitter for the latest news emerging from #DDW18.